Drug Shortage Report for PRED FORTE
Report ID | 171004 |
Drug Identification Number | 00301175 |
Brand name | PRED FORTE |
Common or Proper name | prednisolone acetate suspension |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | PREDNISOLONE ACETATE |
Strength(s) | 1% |
Dosage form(s) | DROPS DROPS |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5mL and 10mL |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-10-04 |
Actual start date | 2022-10-04 |
Estimated end date | 2023-08-28 |
Actual end date | 2023-08-24 |
Shortage status | Resolved |
Updated date | 2024-01-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-10-04 | French | Compare |
v1 | 2022-10-04 | English | Compare |